COPD drug doses Flashcards
SABA Salbutamol (Ventolin®) MDI strength and dose
Onset: 2-5 min
Duration: 3-5 hr
100 mcg
2-4 puffs prn
SABA Salbutamol (Ventolin®) Neb strength and dose
Onset: 2-5 min
Duration: 3-5 hr
1 mg/mL (other strengths avail)
2.5 mg/neb (q4-6h)
SABA Salbutamol (Ventolin®) dosage forms
MDI Neb 1 mg/mL (other strengths avail) DH PO – tablets
SABA
Terbutaline (Bricanyl®)
Onset: 5-30 min
Duration: 3-5 hr
Slower onset than salbutamol
0.5 mg
500 mcg (1 puff) prn (q4- 6)
SABA
Terbutaline (Bricanyl®)
dosage form
TH
LABA
Formoterol
Oxeze®
Onset: 3-5 min
Peak: 15 min
Duration: 12 hr
TH
(6,12mcg)
6-12 mcg bid
LABA
Formoterol
Floradil®®
Onset: 3-5 min
Peak: 15 min
Duration: 12 hr
Inh caps
12 mcg
6-12 mcg bid
LABA
Salmeterol
(Serevent®)
Onset: 10-20 min
Duration: 12 hr
Diskus
50 mcg
50 mcg Bid
LABA
Indacaterol
(Onbrez®)*
Onset: 5 min
Peak: 2-4 hr
Dur: > 24 hr
BH
75 mcg
75 mcg daily
LAMA
Spiriva Tiotropium
HH
Onset: 1-3 hr
Duration: 24hr
18 mcg
18 mcg daily
1 cap inh
LAMA
Spiriva Tiotropium
Respimat
Onset: 1-3 hr
Duration: 24hr
2.5 mcg 5 mcg ( = 2-inh once daily
LAMA
Seebri
Glycopyrronium
Onset: 5 min
Duration :>24 hrs
50 mcg BH
1 inhalation (cap) daily
LAMA
Tudorza Aclidinium
Onset: 10 min
Duration: 12 hr
400 mcg PI genuair
1 inhal bid
Incruse Umeclidinium
Onset: 5-15min
Duration: 24 hrs
Ellipta DPI
62.5 mcg
1 inhal daily
Combination LABA/LAMA’s
Duaklir®
Formoterol /Aclidinium
Genuair PI
12/400 mcg
1 inhalation BID
Combination LABA/LAMA’s
Inspioloto
Olodaterol/Tiotropium
Respimat
2.5/2.5 mcg
2 inhalations once daily
Combination LABA/LAMA’s
Ultibro®
Indacaterol/Glycopyrronium
BH
110/50 mcg
1 inhal (cap) once daily
Combination LABA/LAMA’s
Anoro
Vilanterol/Umeclidinium
Ellipta DPI
25 mcg/62.5 mcg 1 inhal (cap) once daily
ICS - read
● Zenhale® (formoterol/mometasone) 5/100, 5/200 – STEP/SA for Asthma only
● Advair 25/125 MDI, 25/250 MDI, 50/100 Diskus – STEP/SA for Asthma only
● Breo Ellipta 25/200 DPI – STEP/SA for Asthma only. Duration of action of vilanterol >24
hrs. Neither fluticasone furoate (FF) or vilanterol are approved as a separate inhaler
● Trelegy Ellipta: first triple combo therapy available – STEP/SA for COPD only
Combination ICS/LAMA/LABA
“For the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, in patients who are not controlled on optimal dual inhaled therapy